Latest news
Sanofi pauses mid-stage lung study amid new CEO’s ‘rigorous portfolio prioritization’ - BioSpaceBioSpace · Thu, 06 Aug 2026 12:35:10 GMTGarijo’s plan to revamp Sanofi: an R&D cleanup, more M&A and a China push - Endpoints NewsEndpoints News · Thu, 30 Jul 2026 15:19:26 GMTSanofi lifts sales growth forecast on Dupixent strength in boost for new CEO - 927thevan.com927thevan.com · Thu, 30 Jul 2026 09:33:52 GMTNew CEO Garijo sketches out vision to reverse Sanofi's fortunes as Q2 delivers impressive sales beat - Fierce PharmaFierce Pharma · Thu, 30 Jul 2026 07:00:00 GMTSanofi’s New CEO Highlights Pipeline Prioritization - DCAT Value Chain InsightsDCAT Value Chain Insights · Thu, 30 Jul 2026 07:00:00 GMTSanofi Shares Slide After CEO Signals Challenges to Fill Drug Pipeline - WSJWSJ · Thu, 30 Jul 2026 07:00:00 GMTSanofi’s new CEO wants more ‘realistic view’ of Phase 3 go/no-go decisions - BioSpaceBioSpace · Thu, 30 Jul 2026 07:00:00 GMTSanofi raises sales outlook on Dupixent strength in boost for new CEO - ET PharmaET Pharma · Thu, 30 Jul 2026 06:59:48 GMT